Difference between revisions of "Part:BBa K4165027"
(→Dry Lab) |
(→Dry Lab) |
||
Line 36: | Line 36: | ||
<tr> | <tr> | ||
<td>0</td> | <td>0</td> | ||
− | <td> | + | <td>3.29</td> |
− | <td> | + | <td>1.12</td> |
− | <td> | + | <td>99.3</td> |
<td>0</td> | <td>0</td> | ||
− | <td>-0. | + | <td>-0.07547</td> |
− | <td>-1. | + | <td>-1.49016</td> |
</tr> | </tr> | ||
</table> | </table> | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
<html> | <html> |
Revision as of 13:43, 13 October 2022
HtrA1 switch 7
This composite part consists of T7 promoter (BBa_K3633015), lac operator (BBa_K4165062), pGS-21a RBS (BBa_K4165016), 6x His-tag (BBa_K4165020), SPINK8 Inhibitor (BBa_K4165010), TD28rev (BBa_K4165006), WWW (BBa_K4165007), H1A peptide (BBa_K4165000) and T7 terminator (BBa_K731721).
Usage and Biology
Switch 7 is used to mediate the activity of HTRA1. It is composed of 3 parts connected by different linkers; an HtrA1 PDZ peptide, a clamp of two targeting peptides for tau or amyloid beta, and a catalytic domain inhibitor. Activating HTRA1 requires a conformational change in the linker, eliminating the attached inhibitor from the active site. The conformational rearrangement can be mediated through the binding of affinity clamp to tau or beta-amyloid. This binding will result in a tension that detaches the inhibitor from the active site.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry Lab
Modeling
The switch was modeled by (Alphafold - Rosettafold - tRrosetta) and the top model was obtained from tRrosseta with a score of 5 out of 6 according to our quality assessment code.
cbeta_deviations | clashscore | molprobity | ramachandran_favored | ramachandran_outliers | Qmean_4 | Qmean_6 |
---|---|---|---|---|---|---|
0 | 3.29 | 1.12 | 99.3 | 0 | -0.07547 | -1.49016 |
Figure 1. The 3D structure of switch 7 protein visualized by Pymol